Westchester Capital Management (New York)’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Westchester Capital Management (New York)’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-32,400	Closed	-$5.6M	–	156
2015 Q1	$5.6M	Buy	+32,400	New	+$4.76M	0.15%	55

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Westchester Capital Management (New York)'s SLXP Position: Q2 2015 in Review

Westchester Capital Management (New York) sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 32,400 shares — an estimated $5.6M sold.

Westchester Capital Management (New York) first reported a position in SLXP in Q1 2015 and held it in 1 quarter. The position peaked at $5.6M in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

Westchester Capital Management (New York) reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
Westchester Capital Management (New York) sold 32,400 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $5.6M.
Westchester Capital Management (New York) first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q1 2015 and held it in 1 quarter.
Westchester Capital Management (New York)'s SALIX PHARMACEUTICALS LTD DEL position peaked at $5.6M in Q1 2015.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Westchester Capital Management (New York)'s 13F filing for Q2 2015, filed 14 Aug 2015.